Product Program year 2021 Source: CMS Open Payments

Xience Sierra Coronary Stent

Device Vascular

PDI 08717648227547

Open in the dashboard

General payments

$126,913

3,486 payments

Research payments

$10,353,111

2,730 payments

Through program year 2021, $126,913 in general payments and $10,353,111 in research payments were reported against Xience Sierra Coronary Stent (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $126,913 3,486
2021 Research $10,353,111 2,730

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $126,913 3,486 payments
Top recipients General payments · program year 2021
  1. Ramtin Agah Mountain View, CA $29,100 23% · 24 payments
  2. Washington Hospital Center Teaching hospital · DC $3,000 2% · 1 payment
  3. Ki Park Interventional Cardiology · Dallas, TX $2,250 2% · 5 payments
  4. Bruce Samuels Cardiovascular Disease · Beverly Hills, CA $739 <1% · 22 payments
  5. Brian Kaminsky Interventional Cardiology · Mechanicsville, VA $712 <1% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Cardiology Internal Medicine $42,512 45% · 505 practitioners
  2. Cardiovascular Disease Internal Medicine $30,955 33% · 366 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $3,839 4% · 71 practitioners
  4. Nurse Anesthetist, Certified Registered $2,572 3% · 49 practitioners
  5. Internal Medicine $2,384 3% · 30 practitioners

The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $41,641 33% · 105 recipients
  2. Texas $9,825 8% · 169 recipients
  3. New Jersey $8,571 7% · 57 recipients
  4. Michigan $8,369 7% · 107 recipients
  5. New York $6,785 5% · 98 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

3,486 general · 2,730 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record